Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure (Q44426645)

2 December 2017

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure (English)

1 reference

2 December 2017

0 references

0 references

ventricular remodeling

1 reference

inferred from title

chronic heart failure

1 reference

inferred from title

author

Dirk J van Veldhuisen

8

object named as

Dirk J van Veldhuisen

1 reference

2 December 2017

Dirk J Lok

1

1 reference

2 December 2017

Sjoukje I Lok

2

1 reference

2 December 2017

Pieta W Bruggink-André de la Porte

3

1 reference

2 December 2017

Erik Badings

4

1 reference

2 December 2017

Eric Lipsic

5

1 reference

2 December 2017

Jan van Wijngaarden

6

1 reference

2 December 2017

Rudolf A de Boer

7

1 reference

2 December 2017

Peter van der Meer

9

1 reference

2 December 2017

12 August 2012

1 reference

Clinical Research in Cardiology

2 December 2017

1 reference

2 December 2017

102

1 reference

2 December 2017

2

1 reference

2 December 2017

103-110

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-012-0500-y

2 December 2017

0 references

cites work

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure--a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Old and new biomarkers of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Biomarkers: optimizing treatment guidance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Galectin-3 in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0500-Y

The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22886030

12 December 2020

inferred from PubMed ID database lookup

Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22886030

12 December 2020

inferred from PubMed ID database lookup

Galectin-3 in heart failure: high levels are associated with all-cause mortality

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22886030

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00392-012-0500-Y

1 reference

2 December 2017

1 reference